131 related articles for article (PubMed ID: 24943970)
1. The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line.
Salis O; Bedir A; Ozdemir T; Okuyucu A; Alacam H
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1602-9. PubMed ID: 24943970
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1.
Salis O; Bedir A; Gulten S; Okuyucu A; Kulcu C; Alacam H
Cancer Biother Radiopharm; 2014 Nov; 29(9):368-75. PubMed ID: 25347557
[TBL] [Abstract][Full Text] [Related]
3. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
4. Proapoptotic effects of heme oxygenase-1 inhibitor on Kasumi-1 cells via the ATF4/CHOP/Ire-1α pathway.
Wei SX; Wang YT; Chai QX; Fang Q; Zhang YM; Wang JS
Genet Mol Res; 2015 Jun; 14(2):5994-6002. PubMed ID: 26125799
[TBL] [Abstract][Full Text] [Related]
5. Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.
Pan MY; Shen YC; Lu CH; Yang SY; Ho TF; Peng YT; Chang CC
Toxicol Appl Pharmacol; 2012 Dec; 265(3):325-34. PubMed ID: 22982536
[TBL] [Abstract][Full Text] [Related]
6. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways.
Do MT; Kim HG; Khanal T; Choi JH; Kim DH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2013 Sep; 271(2):229-38. PubMed ID: 23707609
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
8. Dual effect of metformin on growth inhibition and oestradiol production in breast cancer cells.
Rice S; Pellat L; Ahmetaga A; Bano G; Mason HD; Whitehead SA
Int J Mol Med; 2015 Apr; 35(4):1088-94. PubMed ID: 25716282
[TBL] [Abstract][Full Text] [Related]
9. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
11. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
12. Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production.
Mdkhana B; Zaher DM; Abdin SM; Omar HA
Phytomedicine; 2021 Mar; 83():153470. PubMed ID: 33524703
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
Amaral I; Silva C; Correia-Branco A; Martel F
Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
[TBL] [Abstract][Full Text] [Related]
14. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
Cai H; Everett RS; Thakker DR
Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
[TBL] [Abstract][Full Text] [Related]
15. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
16. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
[TBL] [Abstract][Full Text] [Related]
18. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
20. Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.
Xin M; Wang Y; Ren Q; Guo Y
Biomed Pharmacother; 2019 Jan; 109():2084-2089. PubMed ID: 30551465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
